Skip to content

CellFE vs TransCode Therapeutics, Inc.

CellFE logo

CellFE

Enabling life-saving therapies with a unique platform for cell engineering

31 employees · est. 2018 · Alameda, United States

VS
TransCode Therapeutics, Inc. logo

TransCode Therapeutics, Inc.

Delivering a cancer-free future

11 employees · est. 2016 · Newton, United States

TransCode Therapeutics, Inc. is the older company (2018 vs 2016).

Side-by-Side Comparison

CellFE TransCode Therapeutics, Inc.
Founded
2018 2016 older
Headquarters
Alameda, United States Newton, United States
Employees
31 11
Industry
Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A Post-IPO Equity
Total Funding
$26.80M $28.05M
Funding Rounds
3 10
Taxonomy
Cell EngineeringMicrofluidicsBiotechGene TherapiesCrispr/Cas9MRNA +6 Cancer TherapeuticsTargeted TherapiesBiomarker TargetingRNA-based TherapiesGene TherapyOncology Research +9
Website
cellfebiotech.com transcodetherapeutics.com
CellFE logo

About CellFE

CellFE is a biotechnology startup with the slogan "Enabling life-saving therapies with a unique platform for cell engineering." Founded in 2018 and headquartered in the United States, CellFE has garnered significant attention in the health care industry. The company has recently received a substanti...

TransCode Therapeutics, Inc. logo

About TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc. is a biotechnology startup founded in 2016, with a mission to deliver a cancer-free future for all cancer patients. The company focuses on the intelligent design and efficient delivery of targeted therapeutics, particularly TTX-MC138, which targets microRNA-10b, consider...

Also comparing in this category

Comparing more than these two?

Get CellFE, TransCode Therapeutics, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does CellFE compare?

A PDF of CellFE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

CellFE was founded in 2018, based in Alameda, United States, with 31 employees. CellFE is a biotechnology startup with the slogan "Enabling life-saving therapies with a unique platform for cell engineering." Founded in 2018 and headquartered in the United States, CellFE has garne. TransCode Therapeutics, Inc. was founded in 2016, based in Newton, United States, with 11 employees. TransCode Therapeutics, Inc. is a biotechnology startup founded in 2016, with a mission to deliver a cancer-free future for all cancer patients. The company focuses on the intelligent design and effic.
CellFE has raised $26.80M and TransCode Therapeutics, Inc. $28.05M. Latest stage: CellFE Series A, TransCode Therapeutics, Inc. Post-IPO Equity.
Both work in Biotechnology and Health Care and list crispr/cas9 among their focus areas.

Compare CellFE with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CellFE on 12 Sep 2024, and TransCode Therapeutics, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout